Total Raised

$7.12M

Investors Count

9

Deal Terms

2

Funding, Valuation & Revenue

5 Fundings

EpiBiome has raised $7.12M over 5 rounds.

EpiBiome's latest funding round was a Acquired for on July 17, 2018.

EpiBiome's latest post-money valuation is from July 2018.

Sign up for a free demo to see EpiBiome's valuations in July 2018 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/17/2018

Acquired

$XXM

0

FY undefined

3

6/23/2016

Debt

$XXM

$XXM

0

FY undefined

10

10/15/2015

Series A

$XXM

$XXM

0

FY undefined

10

4/1/2015

Incubator/Accelerator

$XXM

0

FY undefined

10

10/16/2014

Convertible Note

$XXM

$XXM

0

FY undefined

10

Date

7/17/2018

6/23/2016

10/15/2015

4/1/2015

10/16/2014

Round

Acquired

Debt

Series A

Incubator/Accelerator

Convertible Note

Amount

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

10

10

10

Start free trial
New call-to-action

EpiBiome Deal Terms

2 Deal Terms

EpiBiome's deal structure is available for 2 funding rounds, including their Acquired from July 17, 2018.

Round

Acquired

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

$XXM

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

EpiBiome Investors

9 Investors

EpiBiome has 9 investors. Locus Biosciences invested in EpiBiome's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/17/2018

7/17/2018

1
Acquired

Corporation

North Carolina

00/00/0000

00/00/0000

Silicon Valley Bank

Subscribe to see more

Diversified Financial Services

California

00/00/0000

00/00/0000

Illumina Accelerator

Subscribe to see more

Incubator/Accelerator

California

00/00/0000

00/00/0000

Viking Global Investors

Subscribe to see more

Asset/Investment Management

New York

00/00/0000

00/00/0000

CRCM Ventures

Subscribe to see more

Venture Capital

California

First funding

7/17/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

7/17/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Silicon Valley Bank

Illumina Accelerator

Viking Global Investors

CRCM Ventures

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Diversified Financial Services

Incubator/Accelerator

Asset/Investment Management

Venture Capital

Location

North Carolina

California

California

New York

California

New call-to-action

Compare EpiBiome to Competitors

P
Phytoform

Phytoform involves in agriculture through genetic modifications in plants. The company works on genome editing and the creation of new crop traits to develop crops that can withstand various challenges. Phytoform collaborates with partners to apply scientific discoveries in the agricultural sector. It was founded in 2017 and is based in Hertfordshire, United Kingdom.

N
Novolytics

Novolytics, formed in 2002, engages in the research, development, and production of phage therapy products to combat antibiotic resistance.

Biome Makers Logo
Biome Makers

Biome Makers is a global AgTech company focused on soil health and technology within the agricultural sector. The company offers biological soil testing and analysis through its BeCrop® technology, which decodes soil biology data to provide intelligence for farmers, retailers, and manufacturers. Biome Makers serves the agricultural community by providing insights that help predict risks and improve yields. It was founded in 2015 and is based in El Macero, California.

ZeaKal Logo
ZeaKal

ZeaKal is a company in the plant trait technology sector. Its offerings include technologies that improve carbon capture and photosynthesis in crops. ZeaKal serves the agriculture industry with an emphasis on food and feed products. It was founded in 2010 and is based in San Diego, California.

Micreos Logo
Micreos

Micreos is a platform biotech company focused on the discovery and development of recombinant proteins for chronic dermatological conditions. The company specializes in engineered endolysin technology, which aims to eliminate harmful pathogens while preserving the health-enhancing microbiome. Micreos's lead therapeutic candidate, MEndoB, is an engineered endolysin that targets Staphylococcus aureus, a pathogen associated with Atopic Dermatitis, with the goal of restoring the skin's natural microbiome. It was founded in 2005 and is based in Baar, Switzerland.

Intralytix Logo
Intralytix

Intralytix, Inc. focuses on developing bacteriophage-based products that control bacterial pathogens in environmental, food processing, and medical domains. The company offers products that target specific harmful bacteria for various applications, including food safety, environmental sanitation, and therapeutic use in humans and animals. It was founded in 1998 and is based in Columbia, Maryland.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.